المؤلفون: Thura, Min, Al-Aidaroos, Abdul Qader, Gupta, Abhishek, Chee, Cheng Ean, Lee, Soo Chin, Hui, Kam Man, Li, Jie, Guan, Yeoh Khay, Yong, Wei Peng, So, Jimmy, Chng, Wee Joo, Ng, Chin Hin, Zhou, Jianbiao, Wang, Ling Zhi, Yuen, John Shyi Peng, Ho, Henry Sun Sien, Yi, Sim Mei, Chiong, Edmund, Choo, Su Pin, Ngeow, Joanne, Ng, Matthew Chau Hsien, Chua, Clarinda, Yeo, Eugene Shen Ann, Tan, Iain Bee Huat, Sng, Joel Xuan En, Tan, Nicholas Yan Zhi, Thiery, Jean Paul, Goh, Boon Cher, Zeng, Qi

المصدر: Nature Communications ; volume 12, issue 1 ; ISSN 2041-1723

الاتاحة: https://doi.org/10.1038/s41467-021-26548-6
https://www.nature.com/articles/s41467-021-26548-6.pdf
https://www.nature.com/articles/s41467-021-26548-6

المؤلفون: Thura, Min, Sng, Joel Xuan En, Ang, Koon Hwee, Li, Jie, Gupta, Abhishek, Hong, Jimmy Ming, Hong, Cheng William, Zeng, Qi

المصدر: Bioscience Reports ; volume 41, issue 9 ; ISSN 0144-8463 1573-4935

الاتاحة: http://dx.doi.org/10.1042/bsr20211491
https://portlandpress.com/bioscirep/article-pdf/doi/10.1042/BSR20211491/921165/bsr-2021-1491.pdf

المؤلفون: Thura, Min, Al-Aidaroos, Abdul Qader, Gupta, Abhishek, Chee, Cheng Ean, Lee, Soo Chin, Hui, Kam Man, Li, Jie, Guan, Yeoh Khay, Yong, Wei Peng, So, Jimmy, Chng, Wee Joo, Ng, Chin Hin, Zhou, Jianbiao, Wang, Ling Zhi, Yuen, John Shyi Peng, Ho, Henry Sun Sien, Yi, Sim Mei, Chiong, Edmund, Choo, Su Pin, Ngeow, Joanne, Ng, Matthew Chau Hsien, Chua, Clarinda, Yeo, Eugene Shen Ann, Tan, Iain Bee Huat, Sng, Joel Xuan En, Tan, Nicholas Yan Zhi, Thiery, Jean Paul, Goh, Boon Cher, Zeng, Qi

المساهمون: Lee Kong Chian School of Medicine (LKCMedicine)

مصطلحات موضوعية: Antibodies, Cancer Immunotherapy, Science::Medicine

وصف الملف: 14 p.; application/pdf

Relation: Nature Communications; Thura, M., Al-Aidaroos, A. Q., Gupta, A., Chee, C. E., Lee, S. C., Hui, K. M., . . . Zeng, Q. (2019). PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein. Nature Communications, 10(1), 2484-. doi:10.1038/s41467-019-10127-x; https://hdl.handle.net/10356/79479; http://hdl.handle.net/10220/49728

الاتاحة: https://hdl.handle.net/10356/79479
http://hdl.handle.net/10220/49728
https://doi.org/10.1038/s41467-019-10127-x

المؤلفون: Thura, Min, Al-Aidaroos, Abdul Qader, Gupta, Abhishek, Chee, Cheng Ean, Lee, Soo Chin, Hui, Kam Man, Li, Jie, Guan, Yeoh Khay, Yong, Wei Peng, So, Jimmy, Chng, Wee Joo, Ng, Chin Hin, Zhou, Jianbiao, Wang, Ling Zhi, Yuen, John Shyi Peng, Ho, Henry Sun Sien, Yi, Sim Mei, Chiong, Edmund, Choo, Su Pin, Ngeow, Joanne, Ng, Matthew Chau Hsien, Chua, Clarinda, Yeo, Eugene Shen Ann, Tan, Iain Bee Huat, Sng, Joel Xuan En, Tan, Nicholas Yan Zhi, Thiery, Jean Paul, Goh, Boon Cher, Zeng, Qi

المساهمون: Lee Kong Chian School of Medicine (LKCMedicine)

مصطلحات موضوعية: Antibodies, Cancer Immunotherapy, Science::Medicine

وصف الملف: 14 p.

Relation: Nature Communications; Thura, M., Al-Aidaroos, A. Q., Gupta, A., Chee, C. E., Lee, S. C., Hui, K. M., . . . Zeng, Q. (2019). PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein. Nature Communications, 10(1), 2484-. doi:10.1038/s41467-019-10127-x; http://hdl.handle.net/10220/49728; http://dx.doi.org/10.1038/s41467-019-10127-x

الاتاحة: http://hdl.handle.net/10220/49728
https://doi.org/10.1038/s41467-019-10127-x

المؤلفون: Thura, Min, Al-Aidaroos, Abdul Qader, Gupta, Abhishek, Chee, Cheng Ean, Lee, Soo Chin, Hui, Kam Man, Li, Jie, Guan, Yeoh Khay, Yong, Wei Peng, So, Jimmy, Chng, Wee Joo, Ng, Chin Hin, Zhou, Jianbiao, Wang, Ling Zhi, Yuen, John Shyi Peng, Ho, Henry Sun Sien, Yi, Sim Mei, Chiong, Edmund, Choo, Su Pin, Ngeow, Joanne, Ng, Matthew Chau Hsien, Chua, Clarinda, Yeo, Eugene Shen Ann, Tan, Iain Bee Huat, Sng, Joel Xuan En, Tan, Nicholas Yan Zhi, Thiery, Jean Paul, Goh, Boon Cher, Zeng, Qi

المساهمون: A*STAR | Institute of Molecular and Cell Biology

المصدر: Nature Communications ; volume 10, issue 1 ; ISSN 2041-1723

الاتاحة: http://dx.doi.org/10.1038/s41467-019-10127-x
https://www.nature.com/articles/s41467-019-10127-x.pdf
https://www.nature.com/articles/s41467-019-10127-x

المؤلفون: Thura, Min, Al-Aidaroos, Abdul Qader, Gupta, Abhishek, Chee, Cheng Ean, Lee, Soo Chin, Hui, Kam Man, Li, Jie, Guan, Yeoh Khay, Yong, Wei Peng, So, Jimmy, Chng, Wee Joo, Ng, Chin Hin, Zhou, Jianbiao, Wang, Ling Zhi, Yuen, John Shyi Peng, Ho, Henry Sun Sien, Yi, Sim Mei, Chiong, Edmund, Choo, Su Pin, Ngeow, Joanne, Ng, Matthew Chau Hsien, Chua, Clarinda, Yeo, Eugene Shen Ann, Tan, Iain Bee Huat, Sng, Joel Xuan En, Tan, Nicholas Yan Zhi, Thiery, Jean Paul, Goh, Boon Cher, Zeng, Qi

المساهمون: CANCER SCIENCE INSTITUTE OF SINGAPORE, BIOCHEMISTRY, MEDICINE, SURGERY, DUKE-NUS MEDICAL SCHOOL

المصدر: Elements

مصطلحات موضوعية: Science & Technology, Multidisciplinary Sciences, Science & Technology - Other Topics

Relation: Thura, Min, Al-Aidaroos, Abdul Qader, Gupta, Abhishek, Chee, Cheng Ean, Lee, Soo Chin, Hui, Kam Man, Li, Jie, Guan, Yeoh Khay, Yong, Wei Peng, So, Jimmy, Chng, Wee Joo, Ng, Chin Hin, Zhou, Jianbiao, Wang, Ling Zhi, Yuen, John Shyi Peng, Ho, Henry Sun Sien, Yi, Sim Mei, Chiong, Edmund, Choo, Su Pin, Ngeow, Joanne, Ng, Matthew Chau Hsien, Chua, Clarinda, Yeo, Eugene Shen Ann, Tan, Iain Bee Huat, Sng, Joel Xuan En, Tan, Nicholas Yan Zhi, Thiery, Jean Paul, Goh, Boon Cher, Zeng, Qi (2021-11-02). PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019). NATURE COMMUNICATIONS 12 (1). ScholarBank@NUS Repository. https://doi.org/10.1038/s41467-021-26548-6; https://scholarbank.nus.edu.sg/handle/10635/208517

الاتاحة: https://scholarbank.nus.edu.sg/handle/10635/208517